Clindamycin-resistant group B Streptococcus and failure of intrapartum prophylaxis to prevent early-onset disease has been reported. - GreenMedInfo Summary
Abstract Title:
Clindamycin-resistant group B Streptococcus and failure of intrapartum prophylaxis to prevent early-onset disease.
Abstract Source:
J Pediatr. 2010 Mar;156(3):501-3. Epub 2010 Jan 13. PMID: 20056242
Article Affiliation:
Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, UT, USA. anne.blaschke@hsc.utah.edu
Abstract:
Guidelines recommend intrapartum antibiotic prophylaxis (IAP) for parturient women who have a screen positive for group B Streptococcus (GBS). Clindamycin should be used for IAP only if the maternal GBS isolate is susceptible. We report a case of clindamycin-resistant GBS disease in a newborn infant whose mother received clindamycin IAP, and we review clindamycin susceptibility testing.
Article Published Date : Mar 01, 2010
Study Type : Human: Case Report
Additional Links
Diseases : Infant Infections : CK(410) : AC(44), Infection: Antibiotic Resistant : CK(529) : AC(223), Neonatal Group B Streptococcal (GBS) Infections : CK(309) : AC(22)
Anti Therapeutic Actions : Intrapartum Antibiotics: Group B Streptococcus : CK(149) : AC(12)
